TIR domain-containing adapter molecule 1 (TICAM1 (also known as TRIF))

TIR domain-containing adapter molecule 1 (TICAM1, also known as TRIF) is a cytoplasmic adaptor protein containing a Toll/interleukin-1 receptor (TIR) domain, essential for MyD88-independent signal transduction downstream of Toll-like receptors, primarily TLR3 and in part TLR4[1][2][3][5]. Upon TLR engagement by pathogen-associated molecular patterns, TICAM1 orchestrates the formation of signaling complexes ("speckles") in which it recruits effectors such as TRAF6 and TBK1, leading to phosphorylation and activation of IRF3 and NF-κB—key drivers of type I interferon and antiviral cytokine production[1][3][5]. TICAM1 plays a central role in the innate immune response to viral infection; defects or cleavage by viruses undermine host immunity[1]. Structurally, TICAM1 oligomerizes via its TIR domain, undergoing both homotypic and heterotypic interactions (especially with TICAM2), and its activity is essential for the formation of higher-order signalosomes crucial for propagating immune signals[5][7]. Defects or targeted inhibition of TICAM1 disrupt downstream pathway activation and raise susceptibility to infectious diseases[1][3][5].

Other names

TRIFTIR-domain-containing adapter-inducing interferon-betaProline-rich, vinculin and TIR domain-containing protein BMyD88-3TICAM-1PRVTIRBPutative NF-kappa-B-activating protein 502HToll-interleukin-1 receptor domain-containing adapter protein inducing interferon betaMGC35334IIAE6

- Inhibition of TICAM1 may suppress type I interferon response, blunting the antiviral defense[1]. - Modulation of its adaptor function (blocking or enhancing its ability to oligomerize or interact with TRAF6, TBK1, etc.) regulates downstream immune responses[2][5].